Overcome Global Medicine Shortages With Innovative Manufacturing

Scientist Using Computer In Lab GettyImages-1370154322

As demand for biologic medications continues to grow, global shortages loom large over developers seeking to provide a reliable supply to patients in need. In 2022, multiple factors contributed to widespread medicine supply disruptions, including the COVID-19 pandemic, geopolitical tensions, inflation, energy prices, export bans, and consumer stockpiling. In the European Union, 29 member countries reported experiencing medicine shortages. The UK faced a hormone replacement therapy (HRT) shortage while the US struggled to maintain ibuprofen stocks and ADHD treatments.

The manufacture of pharmaceuticals is typically highly concentrated, and with a relatively small number of facilities and suppliers, compared to existing and latent demand, any disruption, such as ongoing regulatory obstacles and raw material shortages, could spiral into a global matter. By nature, biologics production processes have high quality requirements and small margins for error. As injectable medicines, they are more susceptible to manufacturing challenges than their small-molecule counterparts. Download the full article to learn more about some of the innovative manufacturing strategies that are helping to build more resilient supply chains, mitigate risk, and prevent potential shortages.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online

FUJIFILM Diosynth Biotechnologies